Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04059159 · ClinicalTrials.gov registry record · NA
Connected Catheter - Safety and Effectiveness Study
A NA study, sponsored by Spinal Singularity.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04059159: Clinical Trial NA study, sponsored by Spinal Singularity.
NCT04059159 is a NA study that was terminated before completion, run by Spinal Singularity. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04059159, a NA study, was terminated before completion, sponsored by Spinal Singularity.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The Connected Catheter is a fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization. It is a sterile, extended-use device that resides fully internally to the male lower urinary tract for an intended use life of up to 7 days per catheter.
Primary Outcome
Rate of participants treated with the Connected Catheter reported with a serious device related adverse event
Interventions
- DEVICE Connected Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-04-07 |
| Phase | NA |
Why NCT04059159 stopped before completion
NCT04059159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Connected Catheter is the first listed.
NCT04059159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04059159 about?
NCT04059159 is a clinical study titled "Connected Catheter - Safety and Effectiveness Study". The Connected Catheter is a fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization. It is a sterile, extended-use device that resides fully internally to the male lower urinary tract for an i...
What is the current status of trial NCT04059159?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2020-10-01. Estimated completion is 2021-04-07.
What interventions are being tested in trial NCT04059159?
The interventions under investigation include: Connected Catheter (DEVICE).
Who is sponsoring clinical trial NCT04059159?
This trial is sponsored by Spinal Singularity, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04059159's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI